MDT

84

-0.14%↓

VEEV

225.63

-0.54%↓

A

106.87

+0.63%↑

WBA

10.96

-0.36%↓

CHE

562.2

+1.12%↑

MDT

84

-0.14%↓

VEEV

225.63

-0.54%↓

A

106.87

+0.63%↑

WBA

10.96

-0.36%↓

CHE

562.2

+1.12%↑

MDT

84

-0.14%↓

VEEV

225.63

-0.54%↓

A

106.87

+0.63%↑

WBA

10.96

-0.36%↓

CHE

562.2

+1.12%↑

MDT

84

-0.14%↓

VEEV

225.63

-0.54%↓

A

106.87

+0.63%↑

WBA

10.96

-0.36%↓

CHE

562.2

+1.12%↑

MDT

84

-0.14%↓

VEEV

225.63

-0.54%↓

A

106.87

+0.63%↑

WBA

10.96

-0.36%↓

CHE

562.2

+1.12%↑

Search

Anavex Life Sciences Corp

Closed

SectorHealthcare

9.58 2.02

Overview

Share price change

24h

Current

Min

9.3

Max

9.63

Key metrics

By Trading Economics

Income

-491K

-12M

EPS

-0.14

Employees

42

EBITDA

-1.8M

-14M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+202.55% upside

Dividends

By Dow Jones

Next Earnings

8 maj 2025

Market Stats

By TradingEconomics

Market Cap

745M

Previous open

7.56

Previous close

9.58

Technical Score

By Trading Central

Confidence

Very Strong Bullish Evidence

Anavex Life Sciences Corp Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

28 kwi 2025, 23:27 UTC

Top News

Woodside Energy Approves $17.5 Billion Louisiana LNG Development -- 2nd Update

28 kwi 2025, 23:07 UTC

Top News

Woodside Energy Approves $17.5 Billion Louisiana LNG Development -- Update

28 kwi 2025, 23:03 UTC

Earnings

Waste Management 1Q Profit Falls, Revenue Misses Estimates

28 kwi 2025, 23:47 UTC

Market Talk

Gold Edges Lower as Traders Assess Mixed Signals From Treasury Secretary Bessent -- Market Talk

28 kwi 2025, 23:17 UTC

Earnings

Jiangxi Copper 1Q Rev CNY111.61B Vs. CNY122.52B >0358.HK

28 kwi 2025, 23:17 UTC

Earnings

Jiangxi Copper 1Q Net CNY1.95B Vs. Net CNY1.71B >0358.HK

28 kwi 2025, 23:13 UTC

Earnings

China Merchants Securities: Higher Interest Income, Fee Income Also Aided 1Q Results>600999.SH

28 kwi 2025, 23:13 UTC

Earnings

China Merchants Securities 1Q Rev CNY4.71B Vs. CNY4.30B >600999.SH

28 kwi 2025, 23:13 UTC

Earnings

China Merchants Securities: Gains From Investments in Financial Instruments Supported Results >600999.SH

28 kwi 2025, 23:13 UTC

Earnings

China Merchants Securities 1Q Net CNY2.31B Vs. Net CNY2.16B >600999.SH

28 kwi 2025, 23:08 UTC

Earnings

China Longyuan Power: 1Q Power Generation Declined 4.42% on Year>0916.HK

28 kwi 2025, 23:08 UTC

Earnings

China Longyuan Power 1H Rev CNY8.14B Vs. CNY8.07B >0916.HK

28 kwi 2025, 23:08 UTC

Earnings

China Longyuan Power 1H Net CNY1.98B Vs. Net CNY2.53B >0916.HK

28 kwi 2025, 23:04 UTC

Earnings

Huaneng Power: 1Q Net Was Mainly Driven By Decline in Domestic Fuel Costs >0902.HK

28 kwi 2025, 23:04 UTC

Earnings

Huaneng Power: Decrease in Electricity Tariffs Weighed on Rev >0902.HK

28 kwi 2025, 23:04 UTC

Earnings

Huaneng Power 1Q Rev CNY60.33B ; Down 7.7% on Year>0902.HK

28 kwi 2025, 23:04 UTC

Earnings

Huaneng Power 1Q Net CNY4.97B; up 8.2% on Year >0902.HK

28 kwi 2025, 23:00 UTC

Earnings

Jiangsu Expressway 1Q Rev CNY4.78B Vs. CNY3.47B >0177.HK

28 kwi 2025, 23:00 UTC

Earnings

Jiangsu Expressway: 1Q Rev Rose Due to Increase in Road Construction Projects >0177.HK

28 kwi 2025, 23:00 UTC

Earnings

Jiangsu Expressway: Decline in Investment Income, Fall in Revenue Post Asset Disposal Weighed on 1Q Net >0177.HK

28 kwi 2025, 23:00 UTC

Earnings

Jiangsu Expressway 1Q Net CNY1.21B Vs. Net CNY1.25B >0177.HK

28 kwi 2025, 22:57 UTC

Top News

Trump Signs Order Requiring Nationwide List of Sanctuary Cities and States -- 8th Update

28 kwi 2025, 22:55 UTC

Earnings

Tsingtao Brewery: Higher Sales Volumes of Beer Supported Results >0168.HK

28 kwi 2025, 22:55 UTC

Earnings

Tsingtao Brewery 1Q Net CNY1.71B Vs. Net CNY1.60B >0168.HK

28 kwi 2025, 22:55 UTC

Earnings

Tsingtao Brewery 1Q Rev CNY10.45B Vs. CNY10.15B >0168.HK

28 kwi 2025, 22:52 UTC

Earnings

S.F. Holding: Results Supported by Higher Contributions From Logistics Business >002352.SZ

28 kwi 2025, 22:52 UTC

Earnings

S.F. Holding 1Q Net CNY2.23B Vs. Net CNY1.91B >002352.SZ

28 kwi 2025, 22:52 UTC

Earnings

S.F. Holding: Cost Controls Also aided 1Q Results >002352.SZ

28 kwi 2025, 22:52 UTC

Earnings

S.F. Holding 1Q Rev CNY69.85B Vs. CNY65.34B >002352.SZ

28 kwi 2025, 22:46 UTC

Earnings

Shandong Gold Mining: Increase in Selling Price of Gold Supported Results>600547.SH

Peer Comparison

Price change

Anavex Life Sciences Corp Forecast

Price Target

By TipRanks

202.55% upside

12 Months Forecast

Average 28.5 USD  202.55%

High 42 USD

Low 15 USD

Based on 2 Wall Street analysts offering 12 month price targets forAnavex Life Sciences Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

2 ratings

2

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

9.26 / 9.45Support & Resistance

Short Term

Very Strong Bullish Evidence

Intermediate Term

Very Strong Bullish Evidence

Long Term

Weak Bullish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Interest expense on debt

EBITDA

Operating profit

$

About Anavex Life Sciences Corp

Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of therapeutics for the treatment of central nervous system diseases. Its lead product candidate is ANAVEX 2-73 for the treatment of Alzheimer's disease and Parkinson's disease, as well as other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder; and infantile spasms, Fragile X syndrome, and Angelman syndrome. The company's drug candidate also comprises ANAVEX 3-71, which is in clinical trial for the treatment of schizophrenia, frontotemporal dementia, and Alzheimer's disease. Its preclinical drug candidates include ANAVEX 1-41 for the treatment of depression, stroke, and neurogenerative disease; ANAVEX 1066 for the potential treatment of neuropathic and visceral pain; and ANAVEX 1037 to treat prostate and pancreatic cancer. The company was incorporated in 2004 and is headquartered in New York, New York.